Abstract | Proteins constitute the majority of nature's worker biomolecules. Designed for specific functions, complex tertiary structures make proteins ideal candidates for analysing natural systems and creating novel biological tools. Owing to both their large size and the need for proper folding, de novo synthesis of proteins has been quite a challenge, leading scientists to focus on modifying protein templates already provided by nature. Recently developed methods for protein modification fall into two broad categories: those that can modify the natural protein template directly and those that require genetic manipulation of the amino acid sequence before modification. The goal of this Review is not only to provide a window through which to view the many opportunities created by novel protein modification techniques‚ but also to act as an initial guide to help scientists find direction and form ideas in an ever-growing field. In addition to highlighting methods reported in the past 5 years, we aim to provide a broader sense of the goals and outcomes of protein modification and bioconjugation in general. While the main body of this paper comprises reactions involving the direct modification of expressed proteins, some further functionalization strategies as well as biological applications are also acknowledged. The discussion concludes by speculating which trends and discoveries will most likely come next in the field.
Over time, proteins have become the most valuable biomolecules among the vast variety of cellular components. Owing to a protein's multifaceted nature, performing many roles both within and outside of the cell cycle, amino acid (AA)-based protein modification can lead to a myriad of diverse applications 1, 2 . This is particularly apparent in the field of bioconjugation, in which therapeutic potential in the treatment of cancer and other medical problems has led to bioconjugates infiltrating the pharmaceutical market (in addition to an already established presence in smaller markets such as biomaterials, textile manufacturing and food processing). With high commercial value resulting from such medical promise, it is not surprising that the toolbox available to chemists is ever-expanding 3 . Enhanced bioavailability, fluorescent tracking, post-translational modification (PTM) insertions and targeted delivery are just a few of the numerous possible applications of protein conjugates 1, 4 . In order for these powerful applications to be realized, however, the protein modification must avoid interfering with protein function. Arguably, the ability to retain protein function is primarily affected by the site and size of the protein modification. Site-selective methods that result in a homogeneous product are thus in demand because they maximize the chance of success in the desired application.
Starting from classical methods that are unable to deliver a site-specific reaction, chemical biologists have been able to improve protein modification procedures and identify routes that circumvent the inherent obstacles of bioconjugation 5 ( Fig. 1) . Some of the most challenging criteria include the need for modifications to occur under mild reaction conditions, in an aqueous environment and in the presence of multiple unprotected chemical entities that can promote cross reactions. Moreover, promoting such reactions under natural biological conditions while also maintaining structural and functional integrity adds an extra level of difficulty. Nevertheless, different methods have been developed that take advantage of reactive, endogenous AA side chains. The nucleophilicity, solvent accessibility and relative abundance of Lys and Cys residues have encouraged scientists to target these side chains using maleimides, N-hydroxysuccinimide (NHS) esters and α-halocarbonyls as electrophiles for modification 6, 7 . Michael addition, activated ester amidation and reductive amination have become particularly popular [6] [7] [8] (Fig. 1) . Each method presents particular advantages and disadvantages, but common motivations for the continued search for optimized protein modification methods centre on improving the reaction rate and product homogeneity.
The strategies employed to achieve site-selective modification can be split into three major categories Post-translational modification (PTM) . A post-translational, covalent protein modification that has critical roles in cell signalling and control of protein activation or function.
Site-selective
Referring to modification methods that target a certain residue over other types of amino acids.
Contemporary approaches to site-selective protein modification
Emily A. Hoyt 1 ( Fig. 1) : those in the realm of nature, for example, enzymatic tags or recognition sites that acknowledge the protein microenvironment around a specific site; those that introduce unnatural or abiotic functional groups by genetic sequence insertions before a subsequent chemical reaction; and those that use previously unexplored chemistry or reaction optimization (for example, selective metal-catalysed or metal-directed reactions) 1, 2, 5, [7] [8] [9] [10] . Among the most successful methods for achieving homogeneous products, genetic engineering is currently the method of choice to incorporate a new AA (either canonical or noncanonical) within the structure of a protein for further functionalization 11 . However, direct native protein modification is arguably the ideal method (avoiding the need for any preparatory genetic or covalent manipulation of the protein) and seems to be a promising emerging strategy, with many more examples being described 7, 12 . This Review focuses on appraising modification methodologies from the past 5 years as well as novel examples of the downstream functionalization and therapeutic biological application of these modifications. Throughout the Review, we include in our descriptions the reaction conditions available from the original reports. In some cases, certain information, such as pH or conversion, is omitted because it is not available. TAble 1 also gives an overview of modification method components and key features that are noted in this Review.
Direct modification of native proteins
With only a select number of reactive groups represented and often repeated throughout the protein sequence, modification of endogenous AAs has been difficult to accomplish with a high level of selectivity. Although challenging, the potential for higher yields owing to a single-step process has inspired efforts to develop such methods. Difficulties with conventional strategies for modifying native protein sequences result from the lack of reaction site specificity (heterogeneous products result from repeated functionalities being modified because the methods are site-selective rather than sitespecific) 1 . Site specificity can avoid the modification of reactive residues that are critical to protein function (for example, catalytic Cys residues). However, functionalization of less reactive side chains often requires harsh reaction conditions that can be detrimental to protein activity 7 . Thus, more creative methods are required, and the past 5 years of research in this area have highlighted two general strategies. The first relies on targeting unique and accessible N-/C-terminal chemical environments present in single-chain proteins 13 . The second focuses instead on protein tertiary structures that create more reactive microenvironments that enable selective modification; for example, ligand-binding and metal-binding sites, hyperreactive side chains and disulfide bonds . and reductive amination (part f) 6, 7 . On the right-hand side, modern methods focused on the improvement of selectivity , reaction efficiency and generality of application are shown. The general modification classifications discussed in this Review , as shown by specific examples, are represented: native protein/endogenous amino acid (AA) side chain modification, engineered canonical AA insertion, engineered noncanonical AA insertion and motif/tag insertion 16, 61, 102, 118 . PTM, post-translational modification.
Homogeneous product
A single product -type and position of modification -is formed. Conversely, heterogeneous products are those in which different and multiple modifications have occurred, including on different amino acids or at various occurrences of the same amino acid type.
Site-specific
Referring to modification methods that target a single occurrence of a particular type of amino acid.
Protein microenvironment
The manipulation of amino acid side chain properties (for example, steric or electric characteristics) and reactivity based on the identity of surrounding amino acids in the protein sequence. Fig. 2a ). Unlike prior amide coupling and esterification strategies, this SET reaction favours the C terminus over carboxylic acid moieties in Glu and Asp residues [17] [18] [19] . Such selectivity originates from increased stability of the C-terminal carbon-centred radical 16 . The aforementioned conditions allow for the selective alkylation of human insulin at the A-chain C terminus. However, using alternate decarboxylative conditions, originally studied for targeting Trp residues at the peptide level, selective modification of the B-chain C terminus was observed (0.5-1 equiv. photocatalyst, 10-30 equiv. Michael acceptor, 10 equiv. K 2 HPO 4 , 2.5-3 h, dimethylformamide, Merck photoreactor (450 nm), 15-38% conversion) 20 . Though the precise reasons for this selectivity remain as yet undetermined, the divergence in these C-terminal modification products showcases the number of factors at play when performing protein conjugation.
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When considering N-terminal modification, the first point to consider is that the N-terminal amine has pK a ≈8, while that of an in-chain Lys ε-amine has pK a ≈10. Thus, not only will the N terminus be charged at physiological pH, encouraging solvent accessibility, but also, in slightly basic environments, the N-terminal amine will be deprotonated and more nucleophilic than those in Lys residues 21, 22 . Although the N-terminal amine pK a is similar to that of Cys (pK a ≈8), Cys residues are lower in abundance and may not be as accessible as the N terminus. Thus, Cys modification can be avoided by using protection steps or by careful, amine-reactive reagent selection 22, 23 . Therefore, targeting the N terminus in a single-chain protein can lead to site-specific modification. Even with such promise, the earliest reported methods targeting the N terminus required high concentrations of modifying reagents and long reaction times 24, 25 . Numerous methods that address this, involving one step, low reagent concentrations and reasonable reaction times, have been reported: oxidative coupling with o-aminophenols (5 equiv. o-aminophenol, 250 equiv. oxidant, 30 min, r.t., pH 7.5; Fig. 2b ), addition of 2-pyridinecarboxaldehydes (2-PCAs, 400 equiv., 16 h, 37 °C, pH 7.5, 33-95% conversion; Fig. 2c ) and reductive alkylation with aldehydes [21] [22] [23] (2 equiv. aldehyde, 5 equiv. reductant, 6-48 h, r.t., pH 6.1, 30-70% conversion; Fig. 2d ). While some N-terminal residue types show higher conversion values than others, only a few have been found to be incompatible (for example, an N-terminal Cys can lead to reductive alkylation) 21, 22 . Such versatility can be even further extended by enzymemediated modification at the N terminus. Butelase 1 has been reported as an Asn-specific and Asp-specific ligase to efficiently conjugate thiodepsipeptide substrates to N-terminal residues (0.001 equiv. butelase 1, 5 equiv. substrate, 2.5 h, 42 °C, pH 6.5, 70-82% conversion; While not tested with Gly , Phe or Pro as C-terminal residues, desired products were observed for all other amino acids (AAs), with lower yields for His, Tyr and Lys terminal AAs
16
. N-terminal modification techniques based on oxidative reactions (part b). The techniques were found to perform best (providing high yield depending on the protein) with Pro in the terminal position. This method cannot be performed in a protein with Cys present outside of the N-terminal position, as it can modify Cys residues regardless of position 23 . Direct aminal formation (part c). This method has been used with all AAs in terminal positions but cannot be performed on proteins with Pro in the second position 22 . Reductive amination (part d). All types of terminal AAs provide high yields with the exception of Cys, as a result of thiazolidine side products 21 . Enzymatic reactions (part e) [21] [22] [23] 26 . Butelase 1 can interact with a variety of terminal AAs other than Pro and prefers the second position to be Ile, Val, Leu or Cys. Most of the terminal-AA-type compatibility studies were performed on peptide platforms 26 .
Human insulin
A protein that is made up of two separate chains of amino acids labelled A and b, bound together by two disulfide bridges.
www.nature.com/natrevchem Fig. 2e) . Butelase 1 has a high substrate tolerance and can successfully perform conjugation with any N-terminal AA other than Pro. The reaction tends to be favoured by the presence of a hydrophobic residue in the second position 26 . Having several conjugation strategies available allows navigation of the complex combinations of disadvantages and advantages in order to choose the optimal modification method for a diverse range of proteins and applications.
While some of the aforementioned methods cannot modify proteins with certain terminal residues, the methods complement each other such that there exists at least one possible method for every terminal residue type. Further advantages and limitations stem from the specific reagents or conditions used. With o-aminophenol oxidative coupling, double modification can be seen at basic pH owing to either Lys modification or dimerization 23 . In the case of 2-PCA, after 12 h at 37 °C, 20-30% of the modified protein is denatured 22 . For the method relying on butelase 1, the short half-life of the thiodepsipeptide reagents must be acknowledged, and the reaction conditions adjusted 26 . These limitations highlight why method diversity is needed: to allow for the choice of a modification method with limitations that will not affect the conjugate application. Such diversity also applies to the various advantages of methods: the use of reductive alkylation maintains the charge on the N-terminal amine, which may be necessary for protein function, and the use of 2-PCA or o-aminophenol can facilitate multiple, site-specific modifications [21] [22] [23] . Optimization of older methods has also led to the progression of N-terminal and C-terminal modification strategies. As an example, Rapoport's salt for oxidation at the N terminus shows an expanded tolerance for different N-terminal residues in higher pH environments (pH ~8.5) 27 . The important advantages to incorporate and limitations to avoid depend on the application of interest. However, the structure and makeup of the protein, the presence of PTMs or the need for the termini to be available for protein function means that other protein modification strategies (those that target in-chain sites) are also in high demand 13, 28 .
In-chain residue modification
Protein modification at in-chain AAs is critical for certain biological applications (for example, profiling inhibition and modulation of enzymatic active sites) 29 . Careful selection of the reaction type, conditions and reagents has enabled such modifications to be achieved using endogenous AAs (by which we mean canonical amino acids present in the natural protein sequence) 7 . One such strategy is the selective targeting of Trp residues (200-300 equiv. sodium trifluoromethanesulfinate, 25 equiv. tert-butyl hydroperoxide, 25 equiv. Met, 5-10 min, 0 °C, pH 6.0, 65-80% conversion; Fig. 3a) . Modification of Trp occurs at a 30-fold faster reaction rate than does modification of Cys, the next most reactive. Trp is a low-abundance residue and is highly likely to be found in the hydrophobic core of the protein. As such, the ability of this method to trifluromethylate Trp selectively is a notable achievement 30 . However, when targeting more common endogenous AAs for modification, strategies may rely on the modification of the most accessible and reactive copy of a repeated residue to achieve site specificity.
Owing to their innate nucleophilicity, Lys residues represent one of the more abundant AAs (~6%) commonly targeted for protein modification 14 . While Lys abundance can lead to extreme product heterogeneity with conventional modification methods (for example, amidation with succinimide-based esters), the tertiary structure of proteins can enable higher levels of specificity as a result of unique, microenvironment-driven pK a changes 1, 14, 15 . A recent study by Cravatt and co-workers observed and quantified the reactivities of 9,000 Lys residues in the human proteome, finding several hundred hyper-reactive cases 14 . Therefore, specific reagents or conditions have been developed to modify the most reactive Lys residues in different proteins. By adjusting the electrophilicity of Michael acceptors, our group has targeted the most reactive Lys residues in proteins while leaving other Lys and Cys residues untouched (1 equiv., 1-2 h, 25-37 °C, pH 8.0, >95% conversion; Fig. 3b ). The design of sulfonyl acrylate reagents was assisted by computational calculations that determined transition states facilitating the desired bond formation 12 . Similarly, a multicomponent reaction involving formaldehyde, acetylene and a catalytic Cu-ligand complex was found to modify a single Lys residue in a handful of different proteins (100 equiv. aldehyde, alkyne and CuI, 400 equiv. ligand, 72 h, r.t., pH 7.8, 40-99% conversion; Fig. 3c ). Conveniently, the N terminus is reversibly protected by the formaldehyde, allowing the reactive Lys residue to be targeted over the N-terminal amine. However, the kinetics for the multicomponent reaction are slower, in addition to the suboptimal use of a Cu(I) catalyst that introduces potential toxicity and requires difficult purification steps 31 . Also reliant on the tertiary structure of target proteins are methods mediated by native metal-binding and ligand-binding sites. Such strategies manipulate the spatial arrangement of reagents and residues such that proximity promotes site-specific labelling. However, these methods rely on two factors: the native presence of a metal-binding or ligand-binding site and a nearby, reactive residue. If these conditions are met, then a substoichiometric amount of the catalytic targeting component can be used 32 . For metal-binding sites, the most recent advances have relied on the use of Pd(II) for the arylation of Cys residues, as exhibited with the site-specific modification of mannosyltransferase 29 (80 equiv. Pd(II) reagent, 500 equiv. aryl halide, 4 h, 65 °C, pH 7.6, >85% conversion; Fig. 3d ). Further arylation techniques and products are discussed in this Review, but a more in-depth and comprehensive review on this type of arylation has been published recently 33 . Meanwhile, for ligand-binding sites, polyproline peptides targeting SH3-domain proteins were used to facilitate a reaction between Tyr residues and aryldiazonium reagents 15 (5 equiv., 2.5 h, r.t., pH 7.4, 30% conversion; Fig. 3e ). Furthermore, targeting ligand-binding sites has also enabled the use of imidazole-1-sulfonyl diazotransfer reagents to convert surrounding amino groups into azide moieties for downstream bioorthogonal functionalization 34 (1 equiv.
Canonical amino acids
The standard 20 amino acid types encoded and inserted naturally by the genetic code and by native protein biosynthesis systems.
SH3-domain proteins
Proteins that contain SH3 domains for the regulation of cytoplasmic signalling pathways.
NAtuRe Reviews | CheMISTRy diazotransfer reagent, 100 equiv. Cu(II) catalyst, 1 h, r.t., pH 7.4; Fig. 3 35, 36 ( Fig. 3 g ). Other binding sites on antibodies have also been taken advantage of for proximity-induced site-specific modification. To avoid disrupting the Fc-binding area (an important part of the antibody for receptor interaction), peptides that bind to the junction between the two heavy chains in a full-length antibody were mutated to contain 4-fluorophenyl carbamate moieties and used to modify a Lys residue proximal to the junction (8 equiv. binding protein, 48 h, 37 °C, pH 8.5, >90% conversion) 37 . However, proximity-induced reactions can also be facilitated by strategies such as a recently reported linchpin-directed method (LDM; 25 equiv. LDM reagent, 6-24 h, r.t. or 37 °C, pH 7.0, 34-57% conversion) 38 . This LDM relies on a Lys-reactive group attached to a His-reactive group via a spacer. First, an intermolecular reaction allows for the Lys-reactive component of the LDM reagent to attach nonspecifically and reversibly to the Lys residues in the target protein. Once the reagent is bound to Lys residues, the His-reactive component has the opportunity to bind irreversibly and intramolecularly to a His in proximity of a bound Lys. The Lys residues are then released by the addition of an aminooxy reagent, leaving only the specific His residues modified 38 . Endogenous AA modification has also been achieved by disulfide rebridging, and several general techniques have been established. Conventional native Cys modification often relies on the reduction in interchain disulfides followed by modification of the free Cys‚ which has the potential to cause protein instability owing to the disruption of structurestabilizing disulfide crosslinks 12 . In disulfide rebridging
Antibodies
Proteins that are composed of two main regions: Fc regions (constant regions for the support and stability of the antibody) and Fab regions (variable regions of the antibody that must be preserved in order to retain affinity and specificity for a corresponding antigen).
Disulfide rebridging
A process by which two Cys residues, revealed by disulfide reduction, reform the disrupted disulfide either through the construction of a mixed disulfide or through the introduction of a synthetic stapling molecule to connect the two residues. . Ligand-binding or metal-binding site directed methods: Cys arylation based on proximity to Asp-regulated binding site (part d), selective modification of Tyr residues proximal to the SH3-binding domain (part e), diazotransfer to Lys proximal to ligand site (part f) and metallopeptide-targeted Asn modification in antibodies using Fc-binding peptides (part g) 15, 29, 34, 36 . Disulfide rebridging: by oxetanes (part h), by watersoluble allyl sulfones (part i), by dibromide-based moieties (part j) and by thiol-yne coupling (part k) 40, [42] [43] [44] [45] [46] [47] . The coloured highlights represent different reactive handles or functionalities added to the protein by the conjugation reactions. NaTFMS, sodium trifluoromethanesulfinate; TBHP, tert-butyl hydroperoxide; TCEP, tris(2-carboxyethyl)phosphine.
www.nature.com/natrevchem methodologies, the disulfide bonds are reformed, and, thus, their structural function is retained after modification. Additionally, disulfides that are selectively modified in these approaches tend to be found towards the exterior of the protein and have structure-stabilizing functions, allowing internal disulfides that are vital for activity to remain protected 39 . However, the size and bulkiness of rebridging reagents must be limited to avoid disruption of the structure of the target protein.
Recently, commercially available oxetane reagents have demonstrated the ideal distance for disulfide rebridging while also improving the stability and activity of therapeutic proteins and antibodies 40 equiv. oxetane, 6-12 equiv. tris(2-carboxyethyl)phosphine (TCEP), 24-48 h, 25-37 °C, pH 8.5, >95% conversion; Fig. 3 h) . Alternatively, unlike their bis-sulfone counterparts 41 , allyl sulfones have been proposed as viable disulfide rebridging reagents with high aqueous solubility and reactivity 42 (2 equiv. allyl sulfone, ~1 equiv. TCEP, 24 h, r.t., pH 7.8, 19% and 28% isolated yield with insulin and lysozyme as model proteins, respectively; Fig. 3i ). Meanwhile, divinylpyrimidine (DVP) was recently reported as a stable rebridging agent for antibody and protein conjugates (10-15 equiv. DVP, 5 equiv. TCEP, 1-2 h, 37 °C, pH 8.0, >95% conversion) 43 . A type of disulfide rebridging reagent for obtaining highly homogeneous antibody drug conjugates (ADCs) with drug-to-antibody ratios (DARs) of 2 was reported: dibromopyridazinedione (dibromo-PBD) derivatives (16 equiv., 80 equiv. TCEP, 16 h, 4 °C, pH 8.0; Fig. 3j ). To achieve this, one compound containing two dibromo-PBD derivatives connected by a linker crosslinks two disulfide bridges. Because there are four interchain disulfide bridges available in immunoglobulin G antibodies, two such dibromo-PBD-linker compounds are used, each with one conjugate payload incorporated 44 . Further reports of dibromo-PBD rebridging reagents for a plug-and-play approach for the production of ADCs and for the attachment of antibody fragments in a specific, favourable orientation to nanoparticles have been published recently 45, 46 . Even photo-mediated disulfide bridging has been explored using a one-pot, thiol-yne conjugation strategy on a reduced antibody fragment (0.8 equiv. initiator, 1 equiv. alkyne reagent, 4 h, 0 °C, UV radiation (365 nm), 40% conversion; Fig. 3k ). The method has proved applicable for a variety of alkyne reagents and has exhibited the potential of photo-mediated disulfide rebridging for therapeutic applications 47 . Despite the potential of these discoveries, drawbacks remain prevalent: not being able to achieve high selectivity, homogeneity, efficiency, reagent stability or conversion; not having control over the position of the conjugation site; and needing a multiple-step synthesis to produce the reagents needed for the modification [29] [30] [31] [35] [36] [37] [38] [39] 42 . The diversity between and within the classes of modification strategies (for example, reactiveresidue targeting, metal-binding and ligand-binding sites and disulfide rebridging) signifies that efforts to modulate and add functionality to proteins via endogenous AAs are becoming more pronounced and promising. When yields are optimized, such strategies have the potential for remarkable academic and industrial relevance, as the protein of interest does not require prior sequence engineering.
Modification via genetic manipulation
The genetic engineering of proteins has proved to be an indispensable methodology for site-selective protein modification and the production of homogeneous bioconjugates. Rather than working only with a scaffold of endogenous AAs, genetic engineering allows for the controlled introduction of a variety of abiotic and biotic chemical handles at designated sites 1 . The potential versatility and generality inherent in the genetic engineering platform make these strategies invaluable for the exploration and modulation of protein function. The discussion of the various, genetically based strategies that follows focuses on the diversity and complementarity of the different method components and potential applications. Such diversity can be evaluated on the basis of certain attributes: multiple modifications; biologically compatible conditions; reaction selectivity; directly added functionality versus an added bioorthogonal handle for subsequent modification; reaction efficiency and stability; method applicability; and modification reversibility. Additionally, the strategies presented here have been categorized into three broader insertion groups: canonical AAs, noncanonical amino acids (ncAAs) and motifs or enzymatic tags.
Canonical amino acid insertion
While direct modification of endogenous AAs can be performed using the same chemical transformations discussed earlier in this section, these methods can often be more broadly applied and successful when the target residue is genetically inserted at specific positions in protein sequences. Although the selectivity is based primarily on chemical functionality, the insertion site in the protein is also of great importance: the site must be accessible to the modifying reagents, and the protein must retain its structure and function. In addition, the insertion and expression of canonical AAs avoid disadvantages and complexities inherent to ncAA and multiple-AA motif insertion. As Cys has been the focus of many recently discovered methods owing to its broad reactivity profile, this section is split into two: methods targeting inserted Cys residues and methods targeting other low-abundance, endogenous residues 6 . Cys insertion. Out of the two most nucleophilic canonical residues (Cys and Lys), Cys remains the residue of interest largely owing to its relative low abundance (~1.9%), high nucleophilicity and ability to react in environments closer to neutral pH 13 . Whether targeted as an endogenous AA or a mutated side chain, the broad scope of Cys reactivity from transfer (that is, atom, electron or hydride) and metal-binding to exchange reactions indicates the incredible number of already determined Cys modification methods. Several recent reviews have focused on Cys-targeted conjugation 6, 48 . Furthermore, Cys residues can be reduced to dehydroalanine (Dha) to extend the reach of an already versatile reactivity profile 6 . The standard Cys reaction for efficiency and selectivity
Conjugate payload
The chemical linker and added functionality (for example, fluorophore or cytotoxic drug) in a protein conjugate.
Noncanonical amino acids
(ncAAs). Amino acids that are most often synthesized and non-proteinogenic (with the exception of Sec and Pyl) and can be inserted either residuespecifically or site-specifically into protein sequences.
Endogenous residues
Amino acid residues that are synthesized by the host organism rather than by artificial synthesis.
NAtuRe Reviews | CheMISTRy has, until recently, been maleimide-based reactions. However, owing to the observation of retro-Michael additions under basic conditions and thiol exchange, in vivo therapeutic applications for maleimide linkages are slowly becoming replaced by more robust linkages 48 . Even with the development of methods to stabilize the maleimide linkage by hydrolysing the thiosuccinimide ring, these strategies prove to be less efficient and result in a mixture of hydrolysed and non-hydrolysed products [49] [50] [51] [52] [53] [54] [55] . Therefore, novel reagents with thiol-specific reactivity have been pursued that lead to irreversible, stable conjugation while attempting to reach efficiencies comparable to maleimide reactions.
While some of these recently discovered reagents add a unique chemical handle at the site of the inserted Cys residue for downstream functionalization, other methods manage to add functionality directly in a single step. Strategies for the efficient insertion of chemical handles include the addition of isobutylene (50-1,000 equiv., 50 equiv. TCEP, 1-6 h, 4 °C to r.t., pH 8.0-9.0; Fig. 4a ) and oxetane bromo-derivatives (1,500 equiv. oxetane, 440 equiv. TCEP, 2-5 h, 37 °C, pH 8.0-11.0, >95% conversion; Fig. 4b ) as electrophilic handles. Both electrophilic handles rely on a bromide leaving group for further modification by alkylation with small molecule nucleophiles. While the isobutylene handle facilitates conjugation under more biocompatible conditions, the oxetane linkage adds advantageous attributes to the conjugate by increasing aqueous solubility and metabolic stability 56, 57 . As electrophiles do not exist endogenously in proteins, these handles create unique sites on the protein for downstream functionalization. Meanwhile, other strategies focus on synthesizing modifying reagents that incorporate the desired functionality upon reaction with the protein.
Even with the variety of reactive partners available for installed chemical handles, high-yielding, simple, one-step processes for conjugation are hotly pursued. Sodium 4-((4-(cyanoethynyl)benzoyl) oxy)-2,3,5,6-tetrafluorobenzenesulfonate (CBTF) is one reagent that fulfils these criteria. CBTF contains both an activated ester for amine functionalization before conjugation and a 3-arylpropiolonitrile moiety that can react with a Cys residue. CBTF displays a high potential for rapid reactions and forms highly stable products 58, 59 (12 equiv. CBTF, 1.1-2.2 equiv. TCEP, 12 h, r.t., pH 6.8; Fig. 4c) . Alternatively, by decorating the aromatic ring with a variety of electron-withdrawing groups and fluorine substituents, fluorobenzene-type reagents have also been explored for the stable and selective S-arylation of Cys residues 60 (2-67 equiv., 16 h, 37 °C, pH 8.3; Fig. 4d ). Other reagents that form stable, irreversible linkages while also introducing desired functionality are carbonylacrylic, allenamide and cyclopropenyl ketone derivatives [61] [62] [63] . Carbonylacrylic reagents succeed in performing the desired modification via a rapid Michael addition in a stoichiometric manner 61 (1-50 equiv., 1-2 h, r.t. to 37 °C, pH 8.0, >95% conversion; Fig. 4e ). Allenamide reagents, being less electron deficient than ketones and esters, react specifically with Cys and avoid modification by common biological nucleophiles 62 (10-25 equiv. allenamide, 10 equiv. dithiothreitol (DTT), 30 min, 37 °C, pH 8.0; Fig. 4 f) . Unlike the carbonylacrylic and allenamide reagents, the cyclopropenyl ketone derivatives, functionalized via amide connections formed by NHS-ester-promoted reactions, rely on ring strain to promote irreversible, rapid formation of stable products 63 (50 equiv. cyclopropenyl ketone, 5 equiv. tris(hydroxypropyl)phosphine, 10 min, r.t., pH 6.0; Fig. 4 g) . Furthermore, both dichlorotetra zine (10 equiv., 1 h, r.t., pH 5.2; Fig. 4 h ) and 2-azidoacrylate (10 equiv., 12 h, r.t., pH 7.4, >85% conversion; Fig. 4i ) reagents have been proposed as being able to directly add functionality in one step in addition to introducing bioorthogonal sites for further functionalization 64, 65 . These dual-functionalization strategies circumvent the need for two ncAA insertions and are very promising for improved theranostic applications 65 . In addition to the more conventional Michaeladdition-type and alkylation-type reactions, metal-based reactions have also been explored for the modification of Cys. However, transition-metal-based reactions have not been pursued to the same extent as metalfree methods owing to common difficulties with complex biomolecules: side reactions with endogenous protic, basic or thiol-containing moieties; heterogeneous product mixtures; catalyst deactivation; and incompatible protein modification conditions 66, 67 . Only recently has the specificity, efficiency and versatility of transition-metal-based chemistry been harnessed thanks to judicious metal and ligand choices 68 . Au(III) (15-20 equiv., 30 min, r.t., pH 8.0; Fig. 4j ) and Pd(II) (1.1-10 equiv., 24 h, 37 °C, pH 8.5, >94% conversion; Fig. 4k ) complexes have been used for the production Out of all the canonical amino acids (AAs) for the installation of chemical handles in proteins, Cys residues have the broadest reactivity profile, as represented by the examples in this figure. The methods have been separated into three classifying groups: metal-free, metal-assisted and reversible reactions. Because the eventual application for the bioconjugate determines the type of chemistry linking the added functionality and the protein, these three categories all represent different mechanistic strategies that would allow these methods to be useful under various circum stances (for example, cleavable linkers for antibody drug conju gates to prevent reliance on release of the attached drug by native cell processes). Metal-free methods: addition of alkyl bromide electrophilic handles via an isobutylene-type and oxetane-type chemical handle (parts a, b); amine functionalization followed by the addi tion of 4-((4-(cyanoethynyl)benzoyl)oxy)-2,3,5,6-tetrafluo robenzenesulfonate (part c); S-arylation by fluoro benzene derivatives (part d); addition of carbon ylacrylic reagents (part e); allenamide addition (part f); cyclopropenyl ketone addition (part g); chloro tetrazine addition (part h); and 2-azidoacrylate addition (part i) [56] [57] [58] [60] [61] [62] [63] [64] [65] . Metal-assisted methods: S-arylation by way of Au(III) or Pd(II) catalysis (parts j, k, respectively) 68, 70 . Reversible methods: addition of 5-methylene pyrrolone derivatives (part l); addition of 4-acetoxy cyclopentenone (part m); 2-formyl phenyl boronic acid addition at the N terminus (part n); and addition of naphthoquinone methide precursors (part o) [71] [72] [73] [74] . PTM, post-translational modification. 
Photohydrolysed
NAtuRe Reviews | CheMISTRy controlled release by increasing pH-thiol exchange or Michael donor addition, respectively; the formation of a thiazolidino boronate product at N-terminal Cys residues by 2-formyl phenylboronic acid (2-FPBA) that dissociates in slightly acidic environments (this particular case shows modification of native N-terminal Cys, 1 equiv., 30 min, r.t., pH 7.0, >95% ; Fig. 4n) ; and the formation of a thioether bond by a fast reaction driven by irradiation at 350 nm of 3-(hydroxymethyl)-2-naphthols (naphthoquinone methide precursors, NQMPs) that can be reversed by irradiation of a dilute solution of labelled conjugate or when mixed with vinyl ether [71] [72] [73] [74] [75] (8-9 equiv., 2-6 min, r.t., pH 7.4, 350 nm irradiation; Fig. 4o ). Such variable processes for controlled release of a Cys residue can lead to information on critical epigenetic roles or reversible modulation of protein function 71, 74 . Additionally, the acidic-environment-driven release of 2-FPBA could be used for endosomal release and delivery of cytotoxic drugs from an ADC construct. Furthermore, combinatorial approaches using these methods have an impact in the field. For example, NQMP-Cys conjugation is orthogonal to standard azide-alkyne click chemistry, allowing for many nuanced, complex reversible and release-catch applications 72, 73 . The methods discussed here cover only a fraction of the applications possible through targeted Cys conjugation alone. Even with risks of disulfide disruption or shuffling resulting from the reduction steps required to produce free Cys thiols, the Cys-based modification strategies pursued by scientists represent a window into the future goals of the site-selective protein modification field. The ultimate goal is to obtain a complete toolkit of strategies that cover everything from transitionmetal-mediated to photoinitiated processes that can allow for dual or reversible modification and can be used in concert with other (orthogonal) methods. Cys modification symbolizes the key concept of site-selective protein modification: the strength and power of the technique are a result of the complementarity inherent in a substantial variety and number of methods.
Other low-abundance canonical amino acids. To supplement engineered Cys residue modification, methods targeting alternative, low-abundance AAs have been explored. Genetically inserted residues that have captured particular interest are Trp, Tyr, Met and His. Apart from all four being of low abundance relative to other canonical AAs, endogenous Met and Trp residues are most commonly found in the hydrophobic interior of the protein 76, 77 . Both low abundance and positioning can increase the likelihood that a genetically inserted copy is the only instance of that residue available for modification. In other words, genetic manipulation can allow the formation of a unique chemical handle. However, owing to the lower reactivity of these four side chains in comparison to that of residues such as Cys and Lys, more extreme or biologically incompatible conditions were initially relied upon 77, 78 . While not all of the methods for modifying these less reactive, low-abundance residues require metal mediation, it is a common approach that can ensure specificity and avoid the need for highly reactive reagents, which may lead to unwanted modification elsewhere on the protein 79, 80 . Fig. 5a ), rendering this, the first Trp modification method, both selective for Trp and able to modify a specific site on Trp residues (that is, modification occurs at Trp C2) 81 . Meanwhile, the reagents used for the organoradical, selective modification of Trp are derivatives of 9-azabicyclo[3.3.1]nonane-3-one-N-oxyl (keto-ABNO). Stabilized on the oxygen bonded to the nitrogen, the radical adds to the indole ring of Trp to achieve a highly homogeneous product 77 (1-5 equiv. keto-ABNO, 0.6-3 equiv. NaNO 2 , 30 min, r.t., pH 7.4, 11-64% conversion; Fig. 5b) . Because of some drawbacks to these methods, including the acidic conditions required for high conversion with keto-ABNO conjugation, metal-mediated strategies act as valuable alternatives for proteins and applications requiring alternate conditions 77 . Metal mediation is also required for certain Tyrselective modification strategies. As the more polar Tyr tends to be at the protein surface, site specificity is somewhat harder to achieve. However, owing to low abundance, even in the case of multiple Tyr modifications, high product homogeneity is still likely 82 . In one instance, iron-containing hemin was reported to catalyse the addition of N-methylated luminol derivatives to the ortho Tyr position in the presence of H 2 O 2 (1 equiv. hemin, 100 equiv. peroxide, 100 equiv. luminol derivative, 1 h, r.t., pH 7.4; Fig. 5c ). The production of a reactive cyclic diazodicarboxyamide intermediate in situ drives the reaction forward 82 . A similar intermediate has been used as the starting reagent for Tyr modification, but the hemin-mediated method avoids the need to store unstable reagents 82, 83 . Whether through coordination or covalent binding, some methods require direct metalation of the protein rather than metal mediation of the modification. A method for Tyr modi fication that uses rhodium(III) chloride and boronic acid to link arene complexes to the ortho position in Tyr (50 equiv. rhodium(III) chloride and boronic acid, overnight, r.t., pH 9.4; Fig. 5d ) has been established recently. The Rh(III) Tyr complexes maintain both a metastability and controlled reversibility (via DTT or H 2 O 2 ) owing to the inorganic linkage 84 . Although still not as highly regarded as metal-free methods, advantages of metal-based reactions have become more apparent and have led to further exploration of novel, specific interactions.
Although they are not yet able to augment protein functionality (aside from facilitating transition metal complex interactions to induce luminescence), methods selectively targeting His with Pt(II) (5 equiv. complex, 1 h, r.t., pH 7.0; Fig. 5e ) and Ru(II) (excess complex, 30 min, r.t., pH 7.0; Fig. 5 f) complexes have been developed for protein labelling and staining. While the interaction between the complexes and His residues has not yet been identified as covalent or noncovalent as a result of conflicting analysis results, the staining or switch-on
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Chemical reactions that can be defined by high reaction and conversion rate, green solvent systems, low by-product levels and broad functional group applicability.
www.nature.com/natrevchem probe protocols developed with these complexes require only 30 min to 1 h to reach completion 79, 80 . As transition metal complexes usually bind nonspecifically to proteins, these complexes may signify new interactions that will inspire novel site-selective modification methods. Aside from Trp-selective, Tyr-selective and His-selective methods, redox-activated tagging of a Met-targeted reaction was also reported using oxaziridine reagents (1.1-10 equiv., 10 min, r.t., pH 7.4, >95% conversion; Fig. 5 g) . Oxaziridine reagents have demonstrated selective oxidation of Met residues to sulfimides, which can then be used as a chemical handle for installing payloads 76 . Similarly targeting Met, hypervalent iodine species were used to create a high-energy sulfonium protein synthon (500-1,667 equiv. iodonium salt, 200-667 equiv. thiourea, 50-167 equiv. TEMPO, 50-167 equiv. formic acid (pH ~3), <5 min, 0-20 °C, 84-95% conversion). While functionalization is possible upon oxidation of Met by incorporating the desired functionality into the iodonium salt, the resulting sulfonium product also has an electrophilic diazo group that allows further modification 85 . Outside of the proteinogenic, canonical AAs, Sec has also made an appearance quite recently in reports of site-specific protein modification (oxidation of Sec: 20 equiv. 2,2ʹ-dithiobis(5-nitropyridine), 15 min, r.t., 79, 80 . g | A metal-free, redox-based reaction targeting Met residues with oxaziridine derivatives 76 . CuAAC, copper-catalysed azide-alkyne cycloaddition.
NAtuRe Reviews | CheMISTRy acidic conditions, not isolated; arene addition: 10 equiv. arene, 5 h, 37 °C, pH 8.0, 23% isolated yield) 86 . This report acknowledges the ability of electron-rich arenes (for example, vancomycin) to attach at the site of an oxidized Sec residue, containing an electrophilic Se-S bond. While modification of the oxidized Sec was shown directly in an affibody, insertion into the full-length antibody was accomplished with a sortase-A-mediated method 86 . Even so, this method shows promise for direct modification of the oxidized Sec in full-length antibodies and larger proteins. All of the methods in this section, while creating novel solutions and tools to unlock unexplored directions, represent an ongoing battle against lower reactivity, lower conversion and lower selectivity when attempting to target inserted, low-abundance AAs (with the exception of Cys).
Noncanonical amino acid insertion
One of the most reliable methods for achieving site specificity for protein modification involves the genetic insertion of ncAAs, containing either unique abiotic or biotic functionalities for subsequent bioorthogonal reactions. In the 1960s, translation of the genetic code was thought to be rigid, but the discovery of Sec and Pyl indicated an inherent flexibility 87 . Schultz and co-workers spearheaded the movement towards the broadly applicable use of mutually orthogonal aminoacyl-tRNA synthetasetRNA pairs (that is, no native tRNA synthetase aminoacylates the orthogonal tRNA and no naturally occurring tRNA is modified by the ortho gonal tRNA synthetase) for recognizing and inserting ncAAs at the site of the amber nonsense codon in Escherichia coli [88] [89] [90] [91] . The amber nonsense codon (that is, UAG) was chosen as a model method owing to efficient incorporation with low levels of error 87 . With such promising foundational methods established, protein modification via genetically inserted ncAAs has progressed both in insertion methodology and the inclusion of novel reactive groups (Fig. 6) .
Methods for the insertion of ncAAs aside from orthogonal aminoacyl-tRNA synthetase-tRNA pairs for amber suppression have been developed over the past few years. These incorporation strategies have focused on the reassignment of the rare Arg-tRNA sense codon (AGG); DNA hybridization chromatography for depletion and replacement of certain tRNAs; a cell-free translation system with in vitro transcripts of tRNA; and Yellow highlights represent protection groups that must be removed to reveal a phosphorylation PTM or an allysine residue that can be hydrolysed to an aldehyde functionality (pTyr and ε-N-(4-azidobenzoxycarbonyl)-δ,ε-dehydrolysine (AcdK), respectively) 100, 101 . Blue highlights show the photo-reactive moieties that allow for further functionalization or crosslinking of the protein 102, [106] [107] [108] . The green highlights show different electrophilic handles incorporated by these ncAAs, while the purple highlight signifies a nucleophilic site for subsequent reactions [103] [104] [105] 107, 108 . ACTK , 2-aryl-5-carboxytetrazole-Lys derivative; AmAzZLys, benzyloxycarbonyl-Lys derivative; FPheK , fluorine-activated aryl carbamate; pNCSF, aryl isothiocyanate; PSCaa, photoswitchable click AA ; pTyr, phosphotyrosine; ThioD, thioester derivative of Asp acid.
Bioorthogonal reactions
Chemical reactions that can be executed in the complex environment of living systems (that is, in the presence of many nucleophiles, reductants and so on) without altering or affecting native processes.
Orthogonal aminoacyl-tRNA synthetase-tRNA pairs These orthogonal pairs can use native protein biosynthesis machinery for the site-specific insertion of noncanonical amino acids and require that no native RNA synthetase be able to aminoacylate the incorporated tRNA and no native tRNA be modified by the incorporated RS.
www.nature.com/natrevchem engineered orthogonal ribosomes 87, [92] [93] [94] . However, to be incorporated into a protein, the ncAA must be synthesized. A review on strategies being developed to make this synthetic process more effective has recently been published 95 . While the chosen method of insertion is crucial for expression efficiency and the ability to perform multiple insertions, the bioorthogonal handles that can be introduced in this way have enabled clean and efficient reactions in cells. Meanwhile, direct functionalization of ncAAs with click chemistry has enabled the precise placement of PTM mimics. The breadth of applications and functionalities based on the genetic incorporation of ncAAs is such that we have discussed here only examples that we consider to be the most representative of the accomplishments of this strategy.
Recently, chemistries have been explored to install accurate PTMs or chemical handles for subsequent crosslinking 96, 97 . Site selectivity is vital for the evaluation of specific PTMs, as these epigenetic modifications have different consequences when translated by corresponding 'reader' proteins in varying contexts 98 . Understanding the role of certain PTMs, especially in histone proteins, can be accomplished through ncAA insertion. Such insertions help decode protein-protein interactions, including those necessary for gene regulation and apoptosis 90 . A novel ncAA, ε-N-2-hydroxyisobutyrylLys (HibK), representing a PTM observed in histones, was recently incorporated in histone proteins using an orthogonal amber suppressor pyrrolysyl-RS pair (3.6-11.9 mg l -1 expression yield). By altering the charge of the Lys residue and adding steric bulk, site-specific insertion of HibK will help determine how the PTM affects the chromatin structure 99 . Additionally, PTMs can be inserted in protected forms if the native form is unstable or too reactive. pTyr (phosphotyrosine) was inserted as a neutral analogue that is both cell permeable and stable in cells (1.0-1.75 mg l -1 expression yield). Acidic conditions were used to reveal the native pTyr (16-48 h, 4 °C, pH 1.0-2.0) 100 . Similarly, a protected allysine resi due in the form of ε-N-(4-azidobenzoxycarbonyl)-δ,ε-dehydrolysine (AcdK) was inserted into histone proteins and epigenetic enzymes (7.0 mg l -1 expression yield). The AcdK undergoes reduction by phosphines to reveal allysine (TCEP, 2 h, r.t., pH 7.0), which hydrolyses and is modified by reductive amination (NaCNBH 3 , 8 h, r.t., pH 7.0) to insert either monomethyllysine or dimethyllysine 101 . Both Lys methylation and phosphorylation PTMs have a substantial impact on cell cycle progression and development, and ncAA insertion has provided methods to facilitate their comprehension.
Unlike the aforementioned examples, novel photoLys ncAAs can insert photo-derivatives (4-40% incorporation), containing diazirine rings, of Lys-based PTMs. These derivatives both approximate and identify possible native protein-protein interactions. The method has yet to be demonstrated in a site-specific manner, but a residue-specific manner based on growing cells in media containing photo-Lys has confirmed its potential for selective Lys replacement in native proteins. Noncovalent, transient PTM interactions can then be captured by covalent bonds formed after the photo-crosslinking of the inserted photo-Lys and the protein of interest (1 equiv., 30-60 min, 25-37 °C, pH 7.5, 365 nm irradiation) 102 . Such crosslinking methods also represent an alternative application for ncAAs: the insertion of chemical handles for subsequent functionalization.
The ability of ncAA insertion to install reactive groups that enable bioorthogonal functionalization has been invaluable to site-selective protein modification research. Chemical handles recently inserted into proteins include fluorine-activated aryl carbamates (FPheK, 3-8 . Similarly, pNCSF forms urea-type, crosslinking bridges between proteins or between proteins and small molecules (3-100 equiv. amine-containing nucleophile, 3-24 h, 37 °C, pH 7.4-8.5) 104 . Meanwhile, ThioD can be modified by amine-based nucleophiles (100 equiv. nucleophile, 20 h, 37 °C, pH 7.4) 105 . While these insertions broaden the scope of reactive groups available for modification in proteins, the sequential steps and long modification reaction times are suboptimal. Photo-mediated methods can circumnavigate these limitations by requiring less time and avoiding the use of excess reagents 96 . The most recent ncAAs developed for photomediation post-insertion are 2-aryl-5-carboxytetrazoleLys derivatives (ACTKs, 0.8 mg l -1 expression yield, 15 min, UV radiation 302 nm), benzyloxycarbonyl-Lys derivatives (AmAzZLys with an amine and azide functionality, 53 mg l -1 expression yield, 15 min, UV radiation 365 nm) and photoswitchable click AAs (PSCaas equipped with azobenzenes modified with an alkene, ketone or chloride; 1.2-1.8 mg l -1 expression yield; 2 min; 365 nm) [106] [107] [108] . While AmAzZLys and PSCaas both need further chemical modification in addition to photo-crosslinking or conformation change via photoswitching, these strategies still represent a progression towards photo-based reactions in this research field 106, 107 . Of all the strategies discussed here, the insertion of photo-Lys represents most clearly the overall direction in which ncAA insertion strategies are moving. As an elegant insertion of multifaceted functionality capable of providing information both on PTMs and on photo-crosslinking modifications, the insertion of photo-Lys has the potential for many applications, especially once site-specific insertion of these ncAAs has been achieved 102 .
Motif insertion and enzymatic methods
To circumvent the synthesis and expression of ncAAs while retaining high levels of specificity, canonical AA motifs have been designed for insertion into protein sequences to modify specific residues. The target residue in the motif is activated by microenvironment manipulation based on the identity of the surrounding AAs or recognition of the motif by a specific enzyme 3, 10, 109 . Several reviews on enzymatic methods for site-selective protein modification have been published recently 110, 111 . Thus, the limitations inherent in targeting ncAAs or native residues based on chemical functional group alone can be overcome. However, the size and position of the inserted motif can cause challenges. In some cases, motifs can be added only at the extremities of proteins owing to the need for increased accessibility or are large enough that insertion compromises protein activity 112, 113 . While the inherent specificity of enzymatic modification is a substantial advantage, the enzyme must be easily obtained and achieve high conversions to be industrially useful A broader substrate range for more general modification is possible with enzyme mediation (for example, tubulin Tyr ligase (TTL) and trypsiligase) 113, 116, 117 . TTL attaches Tyr derivatives to the C-terminal residue in an inserted Tub-tag at the C terminus of the target protein 113 (200 equiv. substrate, 0.02-0.2 equiv. TTL, 1-3 h, 37 °C, pH 7.0, 99% conversion, 14-AA tag; Fig. 7b ). Meanwhile, owing to the reversibility often observed in enzymatic reactions, the proteinase trypsiligase can also be used for ligation. While competing hydrolysis reactions generally limit this activity, an activation domain on trypsiligase that allows only proteinase activity when interacting with specific substrates (that is, substrate-activated catalysis) allows promotion of the ligase activity. Therefore, the YRH recognition tag for trypsiligase can be inserted at the N terminus of the target protein, the Y-R bond broken and the guanidinophenyl ester derivative (OGp) added 117 (first step: 0.05 equiv. trypsiligase, 0.5 equiv. Zn(II) additive, 1-18 h; second step: 3-5 equiv. OGp, 30-60 min, 4-20 °C, pH 7.8, >95% conversion, 3-AA tag; Fig. 7c ). While still limited to modification at the protein extremities, a diverse population of substrates can be used, and the specificity of the enzyme can lead to higher likelihood of orthogonality with other modification methods.
Owing to the recent discovery of short sequences that each feature a particularly reactive AA (so-called clever peptides), enzymes are sometimes unnecessary for site-specific modification directed by motif insertion. Most recently, the activation of specific Cys residues for modification by aza-dibenzocyclooctyne (DBCO), 2-cyanobenzothiazole (CBT) and perfluoroaromatic reagents has been reported [118] [119] [120] . The DBCO-tag facilitates modification of a Cys residue by DBCO derivatives at either terminus of a target protein. Thiol-yne reactions have gained interest recently as an underdeveloped click reaction but have struggled with site specificity; the use of a tag enables a more selective and rapid reaction to occur 119 (20 equiv. DBCO, 20-100 equiv. DTT, 4-16 h, 37 °C, pH 8.0, 80-90% conversion, 7-AA tag; Fig. 7d) . Similarly, the fusion tag targeting Cys-CBT reactivity, installed at the N terminus, avoids protection or proteinase steps before modification 120 (100 equiv. CBT, 200 equiv. TCEP, 1 h, 37 °C, pH 7.4-8.5, 12-71% conversion, 11-AA tag; Fig. 7e) . Meanwhile, the π-clamp for the targeting of Cysperfluoroaromatic reactivity achieved the goal of site specificity with only 4 AAs in the motif (20-26 equiv. perfluoroaromatic, 400 equiv. TCEP, 2-6 h, 37 °C, pH 8.0, >95% conversion, 4-AA tag; Fig. 7 f) . On the basis of computationally calculated peptide conformations and energy pathways, the perfluoroaromatic reagents are hypothesized to be recognized by the Phe residues, bringing the reagent into the vicinity of the activated Cys 118 . Recently, another Cys activation-based tag (Distag) was reported that differentiates between free Cys and disulfide bond reactivity, allowing the free Cys to first be modified with a maleimide reagent followed by the reduction and rebridging of the disulfide bond (6-AA tag, free Cys modification: 2 equiv. maleimide reagent, overnight, 15 °C, pH 7.4, 75% conversion; disulfide rebridging: 2 equiv. allyl sulfone reagent, 2 equiv. TCEP, 24 h, 15 °C, pH 7.8, 55% conversion). The Dis-tag allows more facile access to dual modifications by incorporating both sites for modification within a sixresidue minimal distance 121 . With no need for enzymatic mediation, the potential for insertion and modi fication of these Cys residues at in-chain positions is higher because of the easier access of smaller molecules to sterically hindered sites.
To complement Cys-targeted methods, motifs that target Lys residues have also been developed. Cyclohexene sulfonamide reagents are known to modify a
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Fig. 7 | Motif and enzymatic tag insertion.
Rather than the insertion of single residues and reliance only on the chemistry of the added functional group to drive selectivity , the insertion of tags allows for manipulation of the microenvironment around specific amino acids (AAs). Such manipulation can lead to elevated reactivity of the targeted AA or to the enzymatic recognition of the inserted tag. In either case, site-specific modification of the targeted residue within the motif or tag occurs. Ideal motif insertion methods allow for site-specific modification at either inchain or terminal sites as well as cause minimal disruption of the protein structure, even with multiple instances of the tag inserted. a | Fluorette fusion for fluorophore functionalization. NAtuRe Reviews | CheMISTRy specific Lys residue (Lys64) over all other endogenous Lys resi dues in human serum albumin (HSA). Therefore, the specific domain, HSAdI, has been fused to protein termini as a reactive platform for Lys site-specific modification 114 (1-50 equiv., 2-24 h, 37 °C, pH 7.4, 197-AA HSAdI; Fig. 7 g) .
In a similar fashion, the unusual activity of the enzyme sortase A has been used to mediate the formation of an isopeptide bond between the ε-amino group of a Lys residue in an inserted pilin domain with the Thr carboxyl group from an LPXTG (where X = any AA) tag-containing substrate 122 (10-100 equiv. LPXTGcontaining substrate, 2 equiv. enzyme, overnight, 32 °C, 75% conversion, 11-AA domain; Fig. 7h) .
Beyond the targeting of Cys and Lys residues, a recently reported method targets a His-Gly-His (His 2 -tag, 1-5 equiv. PEGylated bis-sulfone, 16 h, 20 °C, 28-39% conversion, 6-AA tag) 123 . With no need for metal chelation, bis-sulfone-modified polyethylene glycol (PEG) chains were shown to selectively modify the two inserted His residues in the tag over other His residues in the protein owing to their close proximity. Performing the reaction at pH 5 avoids modification of other residues and, combined with the low abundance of His, leads to high levels of selectivity 123 .
Even with the discovery of novel activities of known enzymes, enzymatic methods learned previously are most commonly optimized by the positioning and length of the recognition tag. In several cases, enzymatic recognition tags have been shortened or adjusted to create more reactive microenvironments 124, 125 . In others, methods have been effective in various positions within the protein structure, allowing multiple tag insertions without affecting protein activity 112, 125 . Even the choice of slightly different reagents and methodology can allow for higher control over product identity as well as the option for a reversible conjugation 126 . Furthermore, the kinetics of enzymatic recognition and transformation, such as for sortase A, can be manipulated and improved through engineering an intramolecular reaction 127, 128 . Successful attempts at one-pot processes have also been performed using several enzymes either in a tandem reaction to finetune the resulting modification or in a simultaneous, dual modification based on orthogonal recognition tags 129, 130 . Even with these improvements, the discovery of the π-clamp represents an influential benchmark in this field. This elegant, short and computationally designed motif accomplishes efficient modification at protein termini and shows promise for in-chain position insertion 118 . Such attributes indicate that future studies will most likely include heavier emphasis on computational methods and creative manipulations of microenvironments rather than randomized peptide assays for the discovery of novel insertion motifs.
Downstream functionalization
When direct modification of the protein sequence is not possible, functionalization can be achieved by inserting or attaching a reactive functional group (a chemical handle). An entire class of selective bioorthogonal reactions has been developed for this purpose and has been promoted by the introduction of ncAAs. This diverse class of reactive pairs has been critical for installing unique functionalities in proteins. If insertion of a specific ncAA proves challenging owing to limited cellular machinery, chemical handles might also be installed by enzymatic or chemical modification of a residuethough this is less attractive purely by virtue of requiring two synthetic steps. Therefore, the toolkit for efficient protein modification is augmented by both new methods for ncAA insertion and the discovery of new bioorthogonal reactions.
However, with each major development, limitations and problems have arisen. The use of large protein tags (for example, GFP) risks affecting protein activity postconjugation. This was circumvented by the introduction of copper-catalysed azide-alkyne cycloaddition (CuAAC) that allowed the attachment of small molecule tags. The CuAAC is one example of click chemistry [131] [132] [133] . The potential toxicity of Cu(I) led to the development of strain-promoted (and copper-free) azide-alkyne cycloaddition (SPAAC) 133, 134 . In attempts to further improve the reaction kinetics, inverse-electrondemand Diels-Alder (IEDDA) reactions were developed 134 . Reaction rate is a highly important criterion in the development of bioorthogonal reactions (rates span from 10
) -molar substrate concentrations can be naturally limited when dealing with large molecular weight biomolecules, and in the case of radiolabelling experiments, reactions must be completed before decay is complete. However, more reactive agents used to achieve faster reactions were also observed to be less stable (for example, trans-cyclooctyne (TCO) and tetrazine derivatives) [135] [136] [137] . Increased reaction rate and reactivity also generally led to difficulties with complementary bioorthogonal reactions for multisite modification 137 . Therefore, bioorthogonal reactions must be designed keeping in mind competing needs for high reaction rates and for reagents to be stable in biological environments, which differ from those simulated with in vitro testing 131 .
To expand the toolkit of bioorthogonal reactions available, novel reaction partners have been reported with comparable reaction rates and increased stability relative to already discovered methods. Most of these recent methods take advantage of alkyne or aldehyde reactivity. Based on SPAAC, a strain-promoted oxidation-controlled cyclooctyne-1,2-quinone cycloaddition (SPOCQ) was established to add temporal control to the reaction. Using periodate oxidation, 1,2-catechols are oxidized to 1,2-quinones that perform SPOCQ cycloaddition with the strained alkyne bicyclo[6.1.0] nonyne (BCN) as an inserted ncAA 138 (4 equiv. quinone, 1 h, r.t., pH 7.4, 90% conversion, k = 496 ± 70 M -1 s -1 ; Fig. 8a ). Phenyl sydnones with a 1,3-dipole, which also use an inserted BCN ncAA, were shown to undergo a [3+2] cycloaddition to produce a stable pyrazole functionality (50 equiv. sydnone, 6 h, 37 °C, pH 8.0, >95% conversion, k = 0.054 ± 0.00067 M -1 s -1
; Fig. 8b ). Although slower than SPOCQ, the sydnone-BCN reaction does display comparable rates to those of SPAAC and crossmetathesis reactions 135 . An alkyne-functionalized ncAA can be coupled with a second, alkyne-functionalized www.nature.com/natrevchem reactant using a Glaser-Hay coupling, producing a linear, stable diyne product (10 equiv. alkyne, >50 equiv. CuI/tetramethylethylenediamine, 4-6 h, 4 °C, 71-93% conversion; Fig. 8c ). Glaser-Hay couplings have recently been optimized for use in an aqueous environment, with the installed diyne product amenable to further modification 139 . Using a similar ncAA handle, ruthenium-catalysed alkyne hydrosilylation has recently been used to form a C-Si bond (10-300 equiv. hydrosilane, 0.05-4.5 equiv. catalyst, 2-24 h, 37 °C, pH 7.4-8.0, 45-50% conversion, k = 1.0 M -1 s -1 ; Fig. 8d ). The gem-disubstituted vinylsilane product lends itself to additional modification, and the overall reaction is complementary to hydrazone formation, allowing for multiple modifications 140 . Aldehyde and ketone reactive handles offer selective reactions and are widely tolerated electrophiles, and, on this basis, interest in the use of hydrazone and oxime linkages has grown 141 . Many biological applications require highly stable products, and thus C-C bond forming reactions are desirable 142 . On the basis of this reasoning, two Knoevenagel-type condensations were reported: trapped (8 equiv. pyrazolone reagent, 16 h, 37 °C, pH 5.5, k = 0.20 M -1 s -1 ; Fig. 8e ) and tandem (8 equiv. pyrazolone, 16 h, 37 °C, pH 7.2; Fig. 8 f) . Both target an fGly residue, inserted by a fGly-generating enzyme (FGE) 143, 144 . Also targeting C-C bond formation, a direct aldol reaction of 2,4-thiazolidinediones with a N-terminal aldehyde (itself produced by a sodium periodate oxidation of a 1,2-aminothiol moiety) was also successful 145 (1,000 equiv., 3 h, 37 °C, pH 6.5, 83% conversion, k = 0.0078 M -1 s -1 ; Fig. 8 g ). An aldol ligation reaction catalysed by an l-Pro derivative was reported (2-20 equiv. aldehyde, 100-500 equiv. catalyst, 1-6 h, 37 °C, pH 7.5, >95% conversion, k = 24 M -1 s -1 ; Fig. 8 h) . The aldehyde functionality was inserted as a protected analogue via a thiazolidineLys (ThzK) ncAA, allowing for both in-chain and extremity modification. An additional aldehyde functionality was then needed to complete the organocatalystmediated protein aldol ligation (OPAL) reaction. OPAL products can then be further modified through oxime ligation 142 . Methods outside alkyne-based and aldehyde-based reactions have also been reported. Generally, the incorporation of a new ncAA allows for these new protocols to be developed. One such ncAA is N-acryloyl-Lys (AcrK). Alkyl phosphine reagents were used to modify AcrK through a phospha-Michael addition, which occurs at a faster rate than thiol addition, as phosphine reagents have been used to activate electrophiles in thiol-ene reactions 146 (30-40 equiv ., 1-5 h, 25-37 °C, pH 6.8-8.8, 80-90% conversion, k = 0.06 ± 0.01 M -1 s -1 ; Fig. 8i) . A quadricyclane (QC)-containing ncAA has also been successfully inserted into proteins. The strained, hydrocarbon reagent was functionalized with nickel bis(dithiolene), leading to a QC ligation cleavable by UV irradiation and orthogonal to common reactions with aldehyde-aminooxy and alkyne-azide pairs 147 (1-2 h, r.t., pH 7.4; Fig. 8j) . Lastly, the reaction between cyclopropenones, inserted as ncAAs, and triarylphosphines was shown to produce α,β-unsaturated amides 148, 149 (20 equiv., 1-4 h, 37 °C, pH 7.0, >95% conversion, k ≥ 20 M -1 s -1 ; Fig. 8k ). The introduction of reversibility and orthogonality into bioorthogonal reactions paves the way for traceless or multisite conjugation applications. In particular, the increase in bioorthogonal reactions discovered raises the likelihood for complementary/orthogonal reactions to achieve multiple, distinct modifications.
In addition to click-type reactions, accurate approximations of PTMs can be installed using methods established for the modification of Dha, which is itself commonly installed by the reduction in an inserted Cys residue 6, 150 . PTMs have also been inserted via synthetic and ncAA methods -these routes, respectively, introduce a modified AA into the sequence during peptide synthesis or use genetic techniques to introduce an ncAA, which is later selectively modified. The synthetic approach is inconvenient, as the PTM can be incorporated easily only into shorter peptides, and the insertion of ncAAs involves being able to obtain the appropriate genetic machinery 151 . Thus, the formation and modification of Dha is a much more attractive option. As Dha insertion marks the addition of an electrophilic moiety, a type of functional group not endogenous to proteins, novel methods to modify Dha side chains at both terminal and in-chain positions have been ardently pursued 152 . Most recently, aza-Michael additions have been demonstrated with amine-based nucleophiles to produce secondary and tertiary amine products 153, 154 ( >300 equiv., 1-4 h, 25-37 °C, pH 8.0-9.0, 40-95% conversion, k = 6.1 × 10 -5 M -1 s -1 ; Fig. 8 l) . These reactions avoid the use of thiol-based nucleophiles to avoid risking the disruption of surface disulfide bonds. While these C-N bonds are representative of a common type in nature and stable between pH 2.8 and pH 12.8, more accurate representations of PTMs need to be attached by C-C bonds at the site of Dha modification 153 . Two recently proposed radical-based mechanisms were offered as solutions. The first uses an alkyl-halide (either iodide or bromide) for the initiation of radical species in combination with NaBH 4 for the prevention of unwanted oxidation and disubstitution (100-2,000 equiv. alkyl-halide, 30 min, 4 °C, pH 4.0-8.0; Fig. 8 m) . Side chains from nonpolar to polar and even charged PTMs were installed using this method 151 . The second took advantage of O-phosphoserine (Sep) insertion followed by dephosphorylation to obtain Dha. Alkyl iodides were then used to modify the Dha using the transmetalation from zinc to copper to form organocopper reagents and produce a radical alkyl species (300 equiv. alkyl iodide, 300 equiv. zinc powder, 100 equiv. organocopper, 30 min, r.t., pH 4.5, >80% conversion; Fig. 8n ). Using this method, all methylated forms of Lys PTMs were successfully formed 155 . Beyond the insertion of PTMs into proteins, quite recently, Dha residues were harnessed as site-specific handles to access isotopic replacement techniques in proteins by performing a hydrogen-deuterium exchange at the α-carbon of the Dha residue, a non-exchangeable site in the protein backbone (first step after Dha formation in deuterated buffer: 15 equiv. Na 3 SPO 3 , 1 h, 37 °C, pH 8.6; second step: PP1 phosphatase, 1 h, 30 °C, pH 8).
Aside from some limitations that result from the formation of epimers at the deuterated site, the ability to isotopically label a protein site-specifically while avoiding complex biosynthetic methods allows for great potential in the monitoring and probing of modification mechanisms 156 . Even with a lack of stereocontrol, the open-ended diversity for insertion at Dha sites has the potential to both unlock unknown protein functionality and redesign others 151 . While the toolkit of promising novel bioorthogonal reactions continues to expand, improvements push older bioorthogonal reactions closer to achieving a balance between reactivity and stability for broader applicability. These improvements include the discovery of a supramolecular-mediated azide-alkyne reaction using cucurbit [6] uril that increases the solubility of reagents and facilitates reactions; the implementation of smaller, more stable 1,2,4-triazines in the place of tetrazines for IEDDA; the fusing of dioxolane to trans-cyclooctene (d-TCO) for increased stability and solubility while conserving a high reaction rate (on the order of ); an increase in selectivity for a diazo-coupling reaction by using 5-hydroxytryptophan instead of Tyr for a reaction with aromatic diazonium ions; and a method that takes advantage of prior knowledge on boronic acid tag capabilities by using the dynamic covalent character of boronic acid interactions with diols as a purification system before reacting the boronic acid with functionalized salicylhydroxamates to form a more stable product 133, 136, 137, 157, 158 . Even with these improvements, strategies must continuously take into account the additional complications added when applications are meant for in vivo use (for example, sodium periodate could not be used for oxidation in vivo, but enzymatic methods for oxidation may be able to replace it) 145 . An account highlighting the process of developing new bioorthogonal reagents and what is still lacking in the current toolbox of reactions and reactive pairs was recently published 159 . At some point, the motivation for bioorthogonal research will have to change from attempts to find novel reactive pairs to optimizing those already discovered for efficient use 147 .
Therapeutic and diagnostic applications
There have been many reports of applications for protein conjugation, but we have limited the discussion here to only the most recent reports that pertain to diagnostics and therapeutic intervention. Recently, there have been many discoveries of novel, controlled and targeted systems for radioimaging and the delivery of therapeutic protein conjugates [160] [161] [162] [163] . These systems rely on a variety of targeting mechanisms: antibodies, nanobodies or cyclic peptides, to gain this increased specificity and control. Both the targeting method and type of payload can be varied. In many cases, the stability and efficacy of the conjugate depend on the payload linker connecting the components 160, 164, 165 . By combining creative targeting and payload choices, site-selective protein modification will continue to open doors to impactful and novel biological applications.
In the field of therapeutic conjugates, ADCs capture most of the attention 160 . However, novel methods have been reported recently to either improve the ADC mechanism of action or to apply the idea of targeted delivery to alternate payloads (for example, radioligands). All of these improvements require the assistance of selective protein conjugation methods 164, [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] . Strategies ranging from conventional to site-specific conjugation are still in use to drive these adjustments and optimizations. Conventional, selective Lys amidation has very recently been reported as a method for conjugating thiol-based histone deacetylase (HDAC) inhibitors to cetuximab antibodies targeting EGFR (TAble 2, entry I). Less than 1% of the injected dosage of ADCs is expected to reach and be internalized by a target tumour, and as a result payloads for ADCs have been thought to require subnanomolar IC 50 values. Meanwhile, HDAC inhibitors have only approximately a 0.07 µM IC 50 value. As the ADCs incorporating HDAC exhibited antitumour effects, these results suggest that such highly toxic drugs are unnecessary and that off-site toxicity may be avoided by using lower-potency drugs 166 . Other payloads outside of the class of highly cytotoxic, anticancer drugs have also been successfully conjugated to antibodies [168] [169] [170] [171] [172] (TAble 2 , entries I-VI). Amazingly, the wide range of applications represented by these antibodypayload constructs is made possible by altering only the payload, conjugation chemistry and linker, exemplifying how antibody conjugates can be viewed as a modular concept.
Similarly, system variability is possible by moving away from the use of full-length antibodies and towards smaller antibody formats or even small molecule ligands as targeting mechanisms. Additionally, while some of these strategies were successful with conventional 135, [138] [139] [140] . Aldehyde-based reactions: trapped Knoevenagel-type condensation (part e), tandem Knoevenagel-type condensation (part f), aldol reaction with 2,4-thiazolidinediones and an N-terminal aldehyde (part g) and organocatalyst-mediated protein aldol ligation with an inserted aldehyde functionality (part h) [142] [143] [144] [145] . Methods aside from alkyne-based and aldehyde-based strategies: phospha-Michael addition (part i), quadricyclane ligation (part j) and triarylphosphinemediated addition to cyclopropenone (part k) [146] [147] [148] . Methods for Dha modification: aza-Michael addition to Dha (part l) and radical-based reactions for the formation of C-C bonds with Dha (parts m, n) 151, [153] [154] [155] . TCEP, tris(2-carboxyethyl)phosphine; TMEDA , tetramethylethylenediamine. ▶ www.nature.com/natrevchem conjugation methods, a higher level of specificity is observed when more homogeneous conjugates have been used, with improvements in efficacy, pharmacokinetic properties and diminished off-site delivery 160 . The instability and tissue penetration issues associated with the use of full-length antibodies for targeting have led to the use of alternative biomolecules with affinity-based targeting abilities [173] [174] [175] [176] (TAble 2 , entries VII-X). Rather than determining new functionality by altering the payload identity, emphasizing the use of smaller targeting mechanisms has led to an increase in antibody-payload construct efficacy. More specifically, such optimizations have uncovered methods for safer payload delivery, more effective payload distribution and improved accessibility to medically relevant areas of the body that have not been explored by systems incorporating full-length antibodies [173] [174] [175] [176] . In addition to methods targeting particular disease treatment, several recent studies have been aimed at illuminating the unknown mechanistic aspects of ADC approaches to drug delivery or to overcome foreseeable future issues related to antibody-targeting applications 164, 167 . As knowledge of the internalization and subsequent intracellular trafficking of ADCs remains quite limited, clever strategies are needed to enhance efficacy. One such strategy uses fluorescence resonance energy transfer (FRET) pairing to gain insight (TAble 2, entry XI). By incorporating a cleavable linker with one FRET fluorophore on the antibody side, attached by a maleimide-engineered Cys linkage, and one on the warhead side of the linker, when the linker is cleaved, both the antibody and payload can still be visualized and monitored. This method revealed the critical role that the cellular background has in internalization of the antibody 167 . Beyond learning more information is the anticipation of future problems in ADC performance, including the evolution of increased drug resistance. Therefore, a recently published report establishes thio-selenomabs through the site-specific insertion of Cys and Sec to enable dual modification of the antibody (TAble 2, entry XII). Such dual modification would allow two different drugs with two different mechanisms of action to be delivered to the target cells and thus potentially hinder the onslaught of resistance 164 . Similarly, a multidomain protein therapeutic has been designed by biotinylation of An alternative strategy for overcoming cancer cell resistance to mechanisms of certain drugs AA , amino acid; ADC, antibody drug conjugate; DBCO, aza-dibenzocyclooctyne; DMF, dimethylformamide; DTT, dithiothreitol; FRET, fluorescence resonance energy transfer ; HDAC, histone deacetylase; HSA , human serum albumin; IgG, immunoglobulin G; ncAA , noncanonical AA ; PET, positron emission tomography ; PODS, phenyloxadiazolyl methylsulfone; RGD, Arg-Gly-Asp; SPAAC, strain-promoted azide-alkyne cycloaddition; SST, somatostatin; TCEP, tris(2-carboxyethyl) phosphine; WTA , wall-teichoic acid.
a The antibody involved in the nucleotide conjugate is the target of a secondary antibody that allows the colorimetric assay to visualize the nucleotide-antibody conjugate incorporation into DNA. 
Upconversion nanoparticles
Nanoscale particles that allow for photon upconversion (the absorption of two lower-energy photons to create one higherenergy, emitted photon) for imaging and sensors in deep tissue environments.
somatostatin (SST) and a Rho inhibitor (C3; TAble 2, entry XIII). The construct (SST3-Avi-C3) is made by the binding of three SSTs to avidin, with one binding site left for the binding of C3. The C3 toxin can work in concert with doxorubicin to increase anti tumour activity through the synergy of the two different mechanisms of attack 177 . Rather than the targeted delivery of a payload, a recent perspective article discusses the advantages of using the antibody-antigen specific relationship for the creation of synthetic vaccines. Synthetic vaccines are generally composed of antigens conjugated to proteins (using a variety of techniques), which, if proved viable, would have a higher safety profile in comparison to that of whole organism-based vaccines. While synthetic vaccines still take advantage of the antibody-antigen specific relationship, therapeutic applications involving protein conjugates also exist outside of antibody-related targeting 178 . One such method involves the novel, N-terminal selective modification of cowpea chlorotic mottle virus capsid, a virus-like particle, using sortase A, allowing for higher encapsulation efficiencies of therapeutics for subsequent delivery 179 . Alternatively, protein-polymer conjugates, PEGylated and beyond, have been reviewed recently owing to their therapeutic relevance 165 . Aside from therapeutic and diagnostic applications, methods for the profiling and modulation of protein function are reliant upon the production of protein conjugates. For example, methods for exploring histone PTMs using protein modification have recently been reviewed 98 . While we have focused on therapeutic conjugates here (with a particular emphasis on antibody-based targeting strategies), the conjugation methods presented in this Review continue to be applied over many different fields of research, and the methods need to adapt and expand to meet ever-changing demands.
Summary and outlook
While the methods in this Review exemplify the major progress made in site-selective protein modification over the past 5 years, scientists have also been determining which direction the field needs to take to move forward. Whether incorporating new reactivities or refurbishing established chemistries, modi fication requirements are determined primarily by the complexity of the targeted biological system. For the modification of endogenous AA side chains, methods targeting the N/C terminus and in-chain residues need to either be tolerant of varying terminal AA types or use the unique tertiary structure of the target protein to improve specificity. These methods have the potential for high-yielding, one-step direct modification that avoids genetic engineering complexities. Both the identity of the target protein and the importance of product homogeneity to the application determine whether these methods may be used. On the other hand, genetic manipulation of the protein before modification allows for exquisite selectivity and versatility. While installed functionalities are limited by natural translational tools and expression yields, high selectivity makes genetic manipulation the most desirable method for achieving homogeneity and has promoted the growth of bioorthogonal reaction types. Both endogenous AA side chain modification and genetic manipulation have played prominent roles in biological applications, especially in therapeutic and diagnostic areas. However, such prominence has also revealed the many ways in which the field can still be improved or expanded.
In general, an accurate prediction of future techniques can be determined by looking to new methods for peptide modification. Many protein modification methods are first proved using small molecules to exhibit functional group reactivity before moving on to peptides and ultimately whole proteins. Peptide studies allow comparisons of varying AA side chains before determining selectivity in longer AA sequences with a complex tertiary structure. As such, methods that have exhibited selectivity on peptides have strong potential for implementation in proteins. However, owing to the tertiary structure and large size of proteins, approximate reactivity with peptides does not necessarily reflect the protein interactions that will occur. A recently reported method addresses this by installing the reactive groups on well-known protein interaction faces 180 . Strategies similar to this, including computational design, calculations and modelling, improve the efficiency and testing for new protein modification chemistries [181] [182] [183] . Alternatively, it is important to acknowledge that older methods continue to develop and improve. This includes adjustments to allow for the installation of several similar or varying functionalities and for use in biological applications even outside of protein conjugation [184] [185] [186] . While refining the methodology can facilitate the discovery of new modification chemistries, the requirements that these new chemistries must fill are reliant on the purpose and demand of the application.
Overall, these motivations and future directions allow insight into how best to assess and select the modification methods and conditions to produce protein conjugates. By keeping in mind the intended application, whether targeted delivery or probing of a biological system, appropriate proteins should first be identified. Subsequently, the protein then determines whether direct, native modification techniques are possible or whether a chemical handle should be installed genetically to promote a bioorthogonal reaction. On the basis of this determination, a more specific method (for example, targeting the N/C terminus or motif insertion) can be chosen according to how best to retain protein activity. If a bioorthogonal reaction is necessary, the application determines the stability, kinetics and reactivity needed. By highlighting specific conditions, this Review aims to guide scientists to helpful methods based on the specific limitations of their circumstances. Between modification methods already available and promising discoveries on the horizon, site-selective protein modification will lead to versatile biological applications more capable of providing critical information not only for therapeutic and diagnostic purposes but also for profiling and modulating protein function to probe and manipulate novel complex systems.
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